 Abstracts will be presented from the TAK-935OV935 soticlestat clinical development program in Dravet syndrome or Lennox-Gastaut syndrome Phase 2 ELEKTRA study and OV101 gaboxadol clinical development program in Angelman syndrome Phase 2 STARS study Abstracts will be presented from the TAK-935OV935 soticlestat clinical development program in Dravet syndrome or Lennox-Gastaut syndrome Phase 2 ELEKTRA study and OV101 gaboxadol clinical development program in Angelman syndrome Phase 2 STARS study 